Gulmez, A.; Coskun, H.; Koseci, T.; Ata, S.; Bozkurt, B.; Cil, T.
Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy. Medicina 2023, 59, 1625.
https://doi.org/10.3390/medicina59091625
AMA Style
Gulmez A, Coskun H, Koseci T, Ata S, Bozkurt B, Cil T.
Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy. Medicina. 2023; 59(9):1625.
https://doi.org/10.3390/medicina59091625
Chicago/Turabian Style
Gulmez, Ahmet, Hatice Coskun, Tolga Koseci, Serdar Ata, Berna Bozkurt, and Timucin Cil.
2023. "Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy" Medicina 59, no. 9: 1625.
https://doi.org/10.3390/medicina59091625
APA Style
Gulmez, A., Coskun, H., Koseci, T., Ata, S., Bozkurt, B., & Cil, T.
(2023). Effect of Microsatellite Status and Pan-Immune-Inflammation Score on Pathological Response in Patients with Clinical Stage III Stomach Cancer Treated with Perioperative Chemotherapy. Medicina, 59(9), 1625.
https://doi.org/10.3390/medicina59091625